These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24461743)

  • 1. MDR tuberculosis challenges global health-care targets.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2013 Dec; 1(10):755. PubMed ID: 24461743
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing the game for multidrug-resistant tuberculosis.
    Ghanashyam B
    Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mycobacterium tuberculosis with extensive resistance].
    Labie D
    Med Sci (Paris); 2007 Feb; 23(2):205-9. PubMed ID: 17291432
    [No Abstract]   [Full Text] [Related]  

  • 4. [MDR tuberculosis].
    Soini H; Vasankari T
    Duodecim; 2014; 130(16):1599-605. PubMed ID: 25269365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.
    Kapata N; Chanda-Kapata P; Bates M; Mwaba P; Cobelens F; Grobusch MP; Zumla A
    Trop Med Int Health; 2013 Nov; 18(11):1386-91. PubMed ID: 24033538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-resistant tuberculosis: time for visionary political leadership.
    Abubakar I; Zignol M; Falzon D; Raviglione M; Ditiu L; Masham S; Adetifa I; Ford N; Cox H; Lawn SD; Marais BJ; McHugh TD; Mwaba P; Bates M; Lipman M; Zijenah L; Logan S; McNerney R; Zumla A; Sarda K; Nahid P; Hoelscher M; Pletschette M; Memish ZA; Kim P; Hafner R; Cole S; Migliori GB; Maeurer M; Schito M; Zumla A
    Lancet Infect Dis; 2013 Jun; 13(6):529-39. PubMed ID: 23531391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).
    Denholm J
    J Travel Med; 2010; 17(3):216. PubMed ID: 20536899
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-resistant tuberculosis in the Republic of Karelia].
    Markelov IuM; Dorodnaia IA
    Probl Tuberk Bolezn Legk; 2007; (8):8-10. PubMed ID: 17915460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untreatable tuberculosis: is surgery the answer?
    Dara M; Sotgiu G; Zaleskis R; Migliori GB
    Eur Respir J; 2015 Mar; 45(3):577-82. PubMed ID: 25726530
    [No Abstract]   [Full Text] [Related]  

  • 10. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a standardised tool to survey MDR-/XDR-TB case management in Europe.
    Sotgiu G; Centis R; D'ambrosio L; De Lorenzo S; D'arcy Richardson M; Lange C; Manissero D; Migliori GB;
    Eur Respir J; 2010 Jul; 36(1):208-11. PubMed ID: 20595168
    [No Abstract]   [Full Text] [Related]  

  • 12. Global spotlight falls on tuberculosis.
    Das P
    Lancet Infect Dis; 2004 Apr; 4(4):188. PubMed ID: 15072057
    [No Abstract]   [Full Text] [Related]  

  • 13. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

  • 14. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of drug resistance on the global tuberculosis epidemic.
    Schluger NW
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S71-5. PubMed ID: 10688153
    [No Abstract]   [Full Text] [Related]  

  • 16. Programmatic versus personalised approaches to managing the global epidemic of multidrug-resistant tuberculosis.
    Chakaya JM; Marais B; du Cros P; Ntoumi F; Mfinanga S; Kapata N; Hasnain SE; Nathavitharana R; Zumla A
    Lancet Respir Med; 2020 Apr; 8(4):334-335. PubMed ID: 32113573
    [No Abstract]   [Full Text] [Related]  

  • 17. The imminent threat of multidrug-resistant tuberculosis in Singapore.
    Chee CB; Khin-Mar KW; Cutter J; Wang YT
    Singapore Med J; 2012 Apr; 53(4):238-40. PubMed ID: 22511044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-drug-resistant central nervous system tuberculosis.
    Murthy JM
    Neurol India; 2012; 60(2):143-5. PubMed ID: 22626692
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-resistant mycobacterium tuberculosis; some data from Sweden, Estonia and Ethiopia.
    Hoffner SE
    Scand J Infect Dis Suppl; 1995; 98():17-8. PubMed ID: 8867172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curing multidrug-resistant tuberculosis: not all about the money.
    Gruber K
    Lancet Respir Med; 2016 Nov; 4(11):870-871. PubMed ID: 27799128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.